There are two long-term objective of this project 1. Is to use a novel I-Domain Antigen Conjugate (IDAC) molecule to target antigenic peptide to APC to control autoimmune diseases. The short-term objectives of this project are to synthesize, formulate, and evaluate the efficacy of Myelin Oligodendrocyte Glycoprotein (MOG) MOG-PEG-IDAC molecules in suppressing Experimental Autoimmune Encephalomyelitis (EAE) in animal models. The MOG-PEG-IDAC molecule is hypothesized to simultaneously bind to major histocompatibility complex II (MHC-II) and intercellular adhesion molecule 1 (ICAM-1) on the surface of antigen-presenting cells (APC). 2. Is to evaluate the efficacy of PLP-PEG-B7AP in suppressing EAE in mice. The PLP-PEG-B7AP molecule is hypothesized to simultaneously bind to the MHC-II and B7 molecule on the surface of the APC. This binding blocks the formation of the "immunological synapse" and will generate the regulatory response to suppress EAE. Two specific aims are proposed to carry out the short-term objectives. The first specific aim is to design MOG-PEG-IDAC molecules. The second specific aim is to evaluate the efficacy of PLP-PEG-B7AP in suppressing EAE in animal models. To date, the synthesis and characterization of the MOG-PEG-IDAC has been completed, along with EAE animal studies of the PLP-PEG-B7AP.
|Advisor:||Siahaan, Teruna J.|
|Commitee:||Berkland, Cory J., Tolbert, Thomas|
|School:||University of Kansas|
|School Location:||United States -- Kansas|
|Source:||MAI 52/01M(E), Masters Abstracts International|
|Subjects:||Pharmacy sciences, Immunology|
|Keywords:||Experimental autoimmune encephalomyelitis, Immunological synapse, Myelin oligodendrocyte glycoprotein|
Copyright in each Dissertation and Thesis is retained by the author. All Rights Reserved
The supplemental file or files you are about to download were provided to ProQuest by the author as part of a
dissertation or thesis. The supplemental files are provided "AS IS" without warranty. ProQuest is not responsible for the
content, format or impact on the supplemental file(s) on our system. in some cases, the file type may be unknown or
may be a .exe file. We recommend caution as you open such files.
Copyright of the original materials contained in the supplemental file is retained by the author and your access to the
supplemental files is subject to the ProQuest Terms and Conditions of use.
Depending on the size of the file(s) you are downloading, the system may take some time to download them. Please be